Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea · Delayed Price · Currency is KRW 2,510.00
+75.00 (3.08%)
At close: Jul 3, 2026
Vivozon Pharmaceutical Market Cap
Vivozon Pharmaceutical has a market cap or net worth of 151.01 billion as of July 2, 2026. Its market cap has decreased by -47.63% in one year.
Market Cap
151.01B
Enterprise Value
171.00B
Revenue
54.86B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,510.00
Market Cap Chart
Since November 18, 2005, Vivozon Pharmaceutical's market cap has increased from 72.45B to 151.01B, an increase of 108.44%. That is a compound annual growth rate of 3.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 151.01B | -24.75% |
| Dec 30, 2025 | 200.68B | -40.93% |
| Dec 30, 2024 | 339.73B | 134.89% |
| Dec 28, 2023 | 144.64B | -2.99% |
| Dec 29, 2022 | 149.09B | -19.87% |
| Dec 30, 2021 | 186.05B | -37.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NOVAREX | 226.90B |
| CellBion | 216.42B |
| DAE HWA Pharmaceutical | 179.90B |
| GC WellBeing | 142.75B |
| Kyung Dong Pharmaceutical | 134.17B |
| PHARMARESEARCH BIO | 133.16B |
| Cosmax Nbt | 131.96B |
| High Tech Pharm | 131.64B |